Morgan Stanley analyst Matthew Grainger called Philip Morris' largest-ever single day decline yesterday, which knocked $25B off its market cap, "difficult to comprehend" and reflective of "a complete crisis of faith in iQOS' potential value creation." However, he notes that a reduction in iQOS share to 16% in 2025 versus his prior 26% expectation would have only a $3 per share impact on his valuation of Philip Morris shares. Grainger, who sees "exceptional value" in Philip Morris shares at current levels, has an Overweight rating and $123 price target on the stock and added that he also views the sympathy weakness elsewhere in the sector as unjustified.